SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-042431
Filing Date
2013-05-16
Accepted
2013-05-16 16:20:02
Documents
7
Period of Report
2013-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-12523_18k.htm 8-K 26478
2 EX-10.1 a13-12523_1ex10d1.htm EX-10.1 1323327
3 GRAPHIC g125231kk13i001.jpg GRAPHIC 8369
4 GRAPHIC g125231kk13i002.jpg GRAPHIC 3675
5 GRAPHIC g125231kk13i003.jpg GRAPHIC 7406
6 GRAPHIC g125231kk13i004.jpg GRAPHIC 3229
7 GRAPHIC g125231kk13i005.jpg GRAPHIC 1841
  Complete submission text file 0001104659-13-042431.txt   1385537
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13851554
SIC: 2834 Pharmaceutical Preparations